Key Financial Data Of Group

ZERIA PHARMCEUTICAL CO., LTD. - Filing #7541241

Concept As at
2023-09-30
2023-07-01 to
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-09-30
2022-07-01 to
2022-09-30
2022-04-01 to
2022-09-30
Key financial data of group
Business results of group
Net sales
36,678,404,000 JPY
68,383,227,000 JPY
33,712,480,000 JPY
Ordinary profit (loss)
5,495,938,000 JPY
7,579,449,000 JPY
5,182,245,000 JPY
Profit (loss) attributable to owners of parent
5,396,776,000 JPY
6,195,865,000 JPY
3,998,580,000 JPY
Comprehensive income
11,254,078,000 JPY
12,857,913,000 JPY
8,069,646,000 JPY
Net assets
75,962,478,000 JPY
65,680,710,000 JPY
61,822,336,000 JPY
Total assets
148,158,847,000 JPY
135,034,536,000 JPY
134,407,745,000 JPY
Basic earnings (loss) per share
56.29
122.43
140.26
31.65
90.41
Diluted earnings per share
Equity-to-asset ratio
0.511 xbrli:pure
0.485 xbrli:pure
0.458 xbrli:pure
Net cash provided by (used in) operating activities
4,964,771,000 JPY
13,157,415,000 JPY
5,332,190,000 JPY
Net cash provided by (used in) investing activities
-2,186,567,000 JPY
-2,574,517,000 JPY
-963,476,000 JPY
Net cash provided by (used in) financing activities
-2,285,403,000 JPY
-7,415,068,000 JPY
-2,119,276,000 JPY
Cash and cash equivalents
18,343,022,000 JPY
16,094,078,000 JPY
15,168,974,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.